Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs FBDIX overlap: 34% of top holdings shared

Bottom line

How much do IBB and FBDIX overlap?

34% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 35.8% of IBB's assets and 23.0% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.

IBB holds far more positions (254 vs 126), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IBBFBDIX
Weight overlap (top 25)34%
Shared holdings7
Weight in shared holdings35.8%23.0%
Total positions254126
Expense ratio0.44%1.01%
Holdings as ofSep 30, 2025Jul 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Holdings IBB and FBDIX have in common

Holding% of IBB% of FBDIXOverlap
Vertex Pharmaceuticals, Inc.7.66%3.54%3.54%
Gilead Sciences, Inc.7.52%3.86%3.86%
Amgen, Inc.7.50%4.39%4.39%
Regeneron Pharmaceuticals, Inc.5.70%3.77%3.77%
Argenx SE3.15%3.62%3.15%
Insmed, Inc.2.95%1.99%1.99%
Neurocrine Biosciences, Inc.1.34%1.82%1.34%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Alnylam Pharmaceuticals, Inc. — 5.68%
  3. IQVIA Holdings, Inc. — 3.18%
  4. Mettler-Toledo International, Inc. — 2.49%
  5. Natera, Inc. — 2.11%
  6. BeOne Medicines Ltd. — 2.11%
  7. Biogen, Inc. — 2.03%
  8. United Therapeutics Corp. — 1.82%
  9. Waters Corp. — 1.77%
  10. Incyte Corp. — 1.62%
  11. Illumina, Inc. — 1.41%
  12. Genmab A/S — 1.38%
  13. Medpace Holdings, Inc. — 1.16%
  14. Exelixis, Inc. — 1.07%
  15. Ionis Pharmaceuticals, Inc. — 1.03%

Only in FBDIX

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  3. Revolution Medicines, Inc. — 3.01%
  4. Guardant Health, Inc. — 2.76%
  5. Ascendis Pharma A/S — 2.56%
  6. Dianthus Therapeutics, Inc. — 2.32%
  7. Mirum Pharmaceuticals, Inc. — 1.98%
  8. Praxis Precision Medicines, Inc. — 1.91%
  9. Spyre Therapeutics, Inc. — 1.87%
  10. Oruka Therapeutics, Inc. — 1.86%
  11. Bridgebio Pharma, Inc. — 1.67%
  12. PTC Therapeutics, Inc. — 1.65%
  13. AstraZeneca plc — 1.51%
  14. Franklin Institutional U.S. Government Money Market Fund — 1.45%
  15. Amylyx Pharmaceuticals, Inc. — 1.32%

Asset mix

Asset typeIBBFBDIX
Stocks99.8%97.0%
Cash & short-term funds13.4%4.6%
Preferred stock—1.0%
Other—0.6%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Country mix

CountryIBBFBDIX
US98.6%82.0%
IE0.5%6.7%
NL4.3%4.5%
CH2.7%1.2%
DK2.2%2.6%
FR—1.7%
GB1.0%1.5%
CA0.6%1.3%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Check another pair

FAQ

How much do IBB and FBDIX overlap?
About 34% by weight. 7 securities appear in both funds' top 25 holdings; they make up 35.8% of IBB's assets and 23.0% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBB and FBDIX have in common?
The largest shared holdings are Amgen, Inc., Gilead Sciences, Inc., Regeneron Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., Argenx SE.
Should I own both IBB and FBDIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBB or FBDIX?
IBB is broader, with 254 positions versus 126 for FBDIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.